Hope House Treatment Center Residential Medical Facility

Hope House Treatment Center Residential Medical Facility

Services:
Facility Operation (e.g., Private, Public)
• Private non-profit organization

Type of Care

• Substance use treatment
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
• Detoxification

Assessment/Pre-treatment

• Screening for substance use
• Comprehensive substance use assessment
• Complete medical history/physical exam
• Screening for mental disorders
• Screening for tobacco use
• Comprehensive mental health assessment

External Source of Medications Used for Alcohol Use Disorder Treatment

• Other contracted prescribing entity

External Opioid Medications Source

• Other contracted prescribing entity
• In-network prescribing entity
• No formal relationship with prescribing entity

Gender Accepted

• Female
• Male

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Hospital inpatient/24-hour hospital inpatient
• Regular outpatient treatment
• Outpatient
• Outpatient methadone/buprenorphine or naltrexone treatment
• Outpatient day treatment or partial hospitalization
• Short-term residential
• Residential detoxification
• Intensive outpatient treatment
• Hospital inpatient treatment
• Hospital inpatient detoxification
• Residential/24-hour residential

Age Groups Accepted

• Adults
• Young Adults

Treatment Approaches

• Relapse prevention
• Brief intervention
• Anger management
• Telemedicine/telehealth therapy
• Substance use disorder counseling
• Trauma-related counseling
• Contingency management/motivational incentives
• Cognitive behavioral therapy
• 12-step facilitation
• Motivational interviewing

Pharmacotherapies

• Acamprosate (Campral®)
• Buprenorphine without naloxone
• Medication for mental disorders
• Naltrexone (extended-release, injectable)
• Buprenorphine with naloxone
• Nicotine replacement
• Naltrexone (oral)
• Buprenorphine sub-dermal implant
• Buprenorphine (extended-release, injectable)
• Clonidine

Facility Smoking Policy

• Smoking permitted in designated area

Testing

• Drug or alcohol urine screening
• HIV testing
• TB screening
• Testing for Hepatitis B (HBV)
• STD testing
• Breathalyzer or blood alcohol testing
• Testing for Hepatitis C (HCV)

Ancillary Services

• Integrated primary care services
• Suicide prevention services
• Transportation assistance
• Case management service
• Domestic violence services, including family or partner
• Acupuncture
• Social skills development
• Early intervention for HIV
• Mental health services

Exclusive Services

• Specially designed program for DUI/DWI clients

Detoxification (medical withdrawal) Services

• Medication routinely used during detoxification
• Benzodiazepines Detoxification
• Alcohol Detoxification
• Opioids detoxification
• Cocaine Detoxification
• Methamphetamines detoxification

Type of Opioid Treatment

• Buprenorphine maintenance
• Prescribes naltrexone
• Relapse prevention with naltrexone
• Prescribes buprenorphine
• Buprenorphine detoxification
• Accepts clients using MAT but prescribed elsewhere
• Maintenance service with medically supervised withdrawal after stabilization
• Lofexidine or Clonidine detoxification

Education and Counseling Services

• Health education services other than HIV/AIDS or hepatitis
• Smoking/vaping/tobacco cessation counseling
• Group counseling
• HIV or AIDS education, counseling, or support
• Hepatitis education, counseling, or support
• Family counseling
• Substance use disorder education
• Individual counseling

Special Programs/Groups Offered

• Adult women
• Clients with co-occurring mental and substance use disorders
• Clients with HIV or AIDS
• Clients who have experienced intimate partner violence, domestic violence
• Young adults
• Veterans
• Criminal justice (other than DUI/DWI)/Forensic clients
• Clients who have experienced sexual abuse
• Clients who have experienced trauma
• Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
• Adult men

Facility Vaping Policy

• Vaping permitted in designated area

Transitional Services

• Naloxone and overdose education
• Outcome follow-up after discharge
• Aftercare/continuing care
• Discharge Planning

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Payment/Insurance/Funding Accepted

• Medicaid
• Federal, or any government funding for substance use treatment programs
• Cash or self-payment
• Private health insurance

License/Certification/Accreditation

• State Substance use treatment agency
• Commission on Accreditation of Rehabilitation Facilities (CARF)
• State department of health
• Drug Enforcement Agency (DEA)

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Recovery Support Services

• Recovery coach
• Mentoring/peer support
• Assistance with obtaining social services
• Housing services
• Self-help groups